Cellular Biomedicine Group’s CAR-T License Agreement With Janssen

Janssen advised Cellular Biomedicine Group CAR-T on the transaction.Cellular Biomedicine Group signed an exclusive collaboration and license agreement with Janssen Biotech, Inc., pursuant to which Janssen will…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now